Edition:
India

Sellas Life Sciences Group Inc (SLS.OQ)

SLS.OQ on NASDAQ Stock Exchange Capital Market

5.72USD
18 Apr 2018
Change (% chg)

-- (--)
Prev Close
$5.72
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
80,194
52-wk High
$19.74
52-wk Low
$3.43

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.97 December 19 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 -- 0 0
(2) OUTPERFORM 2 -- 0 0
(3) HOLD 0 -- 1 1
(4) UNDERPERFORM 0 -- 0 0
(5) SELL 0 -- 0 0
No Opinion 0 -- 0 0
Mean Rating 2.00 -- 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 --
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 0.00
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.97 -0.97 -0.97 -4.80
Quarter Ending Sep-18 1 -0.71 -0.71 -0.71 -6.00
Year Ending Dec-18 2 -2.84 -2.30 -3.37 -21.90
Year Ending Dec-19 2 -2.21 -1.94 -2.49 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00
Quarter Ending Dec-16 0.00 0.00 0.00 0.00
Quarter Ending Sep-16 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 -- -- --
Quarter Ending Sep-18 0.00 0.00 -- -- --
Year Ending Dec-18 0.00 0.00 -- -- 0.00
Year Ending Dec-19 0.00 0.00 -- -- --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 -- --
Quarter Ending Sep-18 0 0 -- --
Year Ending Dec-18 0 0 -- --
Year Ending Dec-19 0 0 -- --
Earnings